Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page updates from Revision: v3.0.1 to v3.0.2, and the Back to Top link has been removed; overall, there are no significant changes to core content, pricing, stock, or time slots.
    Difference
    0.1%
    Check dated 2025-09-14T20:02:32.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T16:59:28.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new lymphoma types and treatment options, while removing several previously listed lymphoma types and related topics. The facility name and location have also been updated.
    Difference
    5%
    Check dated 2025-08-31T12:09:14.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.6%
    Check dated 2025-08-24T08:06:32.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:40:44.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:34:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.